3,4-methylenedioxyamphetamine has been researched along with Inflammatory Bowel Diseases in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hummel, TZ | 1 |
| Tak, E | 1 |
| Maurice-Stam, H | 1 |
| Benninga, MA | 1 |
| Kindermann, A | 1 |
| Grootenhuis, MA | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Psychosocial developmental trajectory of adolescents with inflammatory bowel disease.
Topics: Adolescent; Adolescent Development; Adult; Chronic Disease; Employment; Female; Humans; Inflammatory | 2013 |